Literature DB >> 21934080

Informed consent in cardiac resynchronization therapy: what should be said?

Daniel B Kramer1, Dan W Brock, Usha B Tedrow.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21934080      PMCID： PMC3641533          DOI： 10.1161/CIRCOUTCOMES.111.961680

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  37 in total

1.  Prevention of sudden death in heart failure.

Authors:  W G Stevenson; L W Stevenson
Journal:  J Cardiovasc Electrophysiol       Date:  2001-01

Review 2.  Does quality of life evidence assist in the selection of patients for resynchronization therapy?

Authors:  Peter A McCullough; William T Abraham
Journal:  Card Electrophysiol Rev       Date:  2003-01

3.  Translating the benefits of cardiac resynchronization therapy widely and wisely: challenges remain.

Authors:  Carl R Reynolds; Mariell Jessup
Journal:  Ann Intern Med       Date:  2011-02-14       Impact factor: 25.391

4.  Preferences for quality of life or survival expressed by patients with heart failure.

Authors:  E F Lewis; P A Johnson; W Johnson; C Collins; L Griffin; L W Stevenson
Journal:  J Heart Lung Transplant       Date:  2001-09       Impact factor: 10.247

5.  Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

Authors:  Wojciech Zareba; Helmut Klein; Iwona Cygankiewicz; W Jackson Hall; Scott McNitt; Mary Brown; David Cannom; James P Daubert; Michael Eldar; Michael R Gold; Jeffrey J Goldberger; Ilan Goldenberg; Edgar Lichstein; Heinz Pitschner; Mayer Rashtian; Scott Solomon; Sami Viskin; Paul Wang; Arthur J Moss
Journal:  Circulation       Date:  2011-02-28       Impact factor: 29.690

6.  Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Authors:  Daniel B Kramer; Aaron S Kesselheim; Dan W Brock; William H Maisel
Journal:  Heart Rhythm       Date:  2010-07-19       Impact factor: 6.343

7.  Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation.

Authors:  David E Haines; Yongfei Wang; Jeptha Curtis
Journal:  Circulation       Date:  2011-05-02       Impact factor: 29.690

8.  Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.

Authors:  Daniel B Kramer; Aaron S Kesselheim; Lisa Salberg; Dan W Brock; William H Maisel
Journal:  Am J Cardiol       Date:  2011-02-04       Impact factor: 2.778

9.  Cardiac-resynchronization therapy for the prevention of heart-failure events.

Authors:  Arthur J Moss; W Jackson Hall; David S Cannom; Helmut Klein; Mary W Brown; James P Daubert; N A Mark Estes; Elyse Foster; Henry Greenberg; Steven L Higgins; Marc A Pfeffer; Scott D Solomon; David Wilber; Wojciech Zareba
Journal:  N Engl J Med       Date:  2009-09-01       Impact factor: 91.245

10.  Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making.

Authors:  Suzanne V Arnold; Carole Decker; Homaa Ahmad; Olawale Olabiyi; Surya Mundluru; Kimberly J Reid; Gabriel E Soto; Sarah Gansert; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-09
View more
  6 in total

1.  Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.

Authors:  Daniel B Kramer; Sharon-Lise T Normand; Rita Volya; Laura A Hatfield
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-12

Review 2.  Shared Decision Making in Cardiac Electrophysiology Procedures and Arrhythmia Management.

Authors:  Mina K Chung; Angela Fagerlin; Paul J Wang; Tinuola B Ajayi; Larry A Allen; Tina Baykaner; Emelia J Benjamin; Megan Branda; Kerri L Cavanaugh; Lin Y Chen; George H Crossley; Rebecca K Delaney; Lee L Eckhardt; Kathleen L Grady; Ian G Hargraves; Mellanie True Hills; Matthew M Kalscheur; Daniel B Kramer; Marleen Kunneman; Rachel Lampert; Aisha T Langford; Krystina B Lewis; Ying Lu; John M Mandrola; Kathryn Martinez; Daniel D Matlock; Sarah R McCarthy; Victor M Montori; Peter A Noseworthy; Kate M Orland; Elissa Ozanne; Rod Passman; Krishna Pundi; Dan M Roden; Elizabeth V Saarel; Monika M Schmidt; Samuel F Sears; Dawn Stacey; Randall S Stafford; Benjamin A Steinberg; Sojin Youn Wass; Jennifer M Wright
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-06

3.  National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.

Authors:  Charlotta Lindvall; Neal A Chatterjee; Yuchiao Chang; Betty Chernack; Vicki A Jackson; Jagmeet P Singh; Joshua P Metlay
Journal:  Circulation       Date:  2015-12-03       Impact factor: 29.690

4.  Cardiac Resynchronization Therapy in Older Patients: Age Is Just a Number, and Yet ….

Authors:  Daniel B Kramer; Daniel A Steinhaus
Journal:  J Card Fail       Date:  2016-10-17       Impact factor: 6.592

Review 5.  Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.

Authors:  B Woods; N Hawkins; S Mealing; A Sutton; W T Abraham; J F Beshai; H Klein; M Sculpher; C J Plummer; M R Cowie
Journal:  Heart       Date:  2015-08-12       Impact factor: 5.994

6.  Geographic and Temporal Variation in Cardiac Implanted Electric Devices to Treat Heart Failure.

Authors:  Laura A Hatfield; Daniel B Kramer; Rita Volya; Matthew R Reynolds; Sharon-Lise T Normand
Journal:  J Am Heart Assoc       Date:  2016-07-28       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.